IDEAYA Biosciences, Inc.
IDYA · Pharmaceutical Preparations · 87.9M shares · +33%/yr ↑ shares · EDGAR filings ↗
Reference price $32.96 · est. market cap ~$2.9B — last insider purchase, 2026-03-02 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Clinical/early-stage biotech — synthetic-lethality oncology clinical, heavy burn, well-funded.
Strengths
- Liquidity — current ratio 11.3 (82nd)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- High convictionHigh conviction — notable institutional holders, insider buying, and a strong balance sheet
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Net lossNet loss (net margin -52.0%)
- Cash burnNegative free cash flow (-73.5M)
- Strong balance sheetStrong balance sheet — $1.0B cash & investments, ~57 quarters of runway
- Insider buyingInsider buying — 1 open-market buy(s) by 1 insider(s) (~$2M, last 6mo) Form 4 ↗
- Revenue declineRevenue -39.7% YoY
- Notable holderHeld by 4 notable fund(s): FMR LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +1 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-72.8%
Net margin
-52.0%
Return on equity
-11.1%
Return on assets
-10.2%
Revenue growth (QoQ)
-39.7%
Current ratio
11.3×
Free cash flow
-$73M
EBITDA
-$157M
Tangible book value
$1.0B
Cash & investments
$1.0B
Cash runway
57q
Stock comp / revenue
21.1%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-02 | Stein Jeffrey | Buy | 50K | $32.96 |
| 2025-11-28 | Snyder Douglas B. | Grant | 1.0K | $16.91 |
| 2025-11-28 | Ruiz Briseno Andres | Grant | 1.3K | $16.91 |
| 2025-05-30 | Snyder Douglas B. | Grant | 1.0K | $16.91 |
| 2025-02-18 | Hata Yujiro S | Option exercise | 13K | $19.52 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-23 | 2026-06-16 | 0001193125-26-279427 ↗ |
| 8-K | 2026-06-10 | 2026-06-08 | 0001193125-26-265833 ↗ |
| 8-K | 2026-06-03 | 2026-06-03 | 0001193125-26-254476 ↗ |
| 8-K | 2026-06-01 | 2026-06-01 | 0001193125-26-251399 ↗ |
| 10-Q | 2026-05-05 | 2026-03-31 | 0001193125-26-206357 ↗ |
| 8-K | 2026-05-05 | 2026-05-05 | 0001193125-26-204944 ↗ |
| 8-K | 2026-05-05 | 2026-05-05 | 0001193125-26-206806 ↗ |
| 8-K | 2026-04-13 | 2026-04-13 | 0001193125-26-151893 ↗ |
| 8-K | 2026-04-09 | 2026-04-08 | 0001193125-26-148777 ↗ |
| 10-K | 2026-02-17 | 2025-12-31 | 0001193125-26-054533 ↗ |
| 8-K | 2026-02-17 | 2026-02-17 | 0001193125-26-052741 ↗ |
| 8-K | 2026-01-12 | 2026-01-11 | 0001193125-26-009653 ↗ |